Physician profile
David M Wild
NPI 1013112671
$4,503.42
in general payments reported to CMS, 2019-2025
38 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $381 · 2021: $926 · 2022: $684 · 2023: $912 · 2024: $725 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $748.89 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Mycarelink |
| Novartis Pharmaceuticals Corporation | $596.49 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $376.65 | 2019-2024 | Xarelto |
| Amgen INC. | $375.06 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $339.38 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $312.46 | 2019-2025 | Farxiga |
| Pfizer INC. | $219.40 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $200.57 | 2019-2024 | Eliquis, Camzyos |
| W. L. Gore & Associates, INC. | $131.51 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.43 | 2020-2025 | Jardiance |
| Boston Scientific Corporation | $97.21 | 2019-2023 | Watchman Flx |
| Heartflow, INC. | $86.09 | 2022-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.75 | 2019-2023 | Lifevest |
| Irhythm Technologies, INC. | $74.70 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Cvrx, INC. | $71.65 | 2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.